Latest News

  • Follow the Money: Bill & Melinda Gates Foundation Fund Diagnostic Breathalyzer, European Innovation Council Backs New RNA-Based Therapies and Diagnostics, More

    Diagnostics World News | Funding for targeting extracellular proteins involved in the pathogenesis of autoimmune, neurological, and other diseases, rapid screening of infectious diseases through volatile organic compounds, a proteomics AI-based platform that comprehensively maps the course of a disease to predict which patients will respond to a given drug, and more.

    Mar 28, 2023
  • Japanese Medical Team Discovers Gut Microbiota to Diagnose and Treat Dementia with Lewy Bodies

    Diagnostics World News | A research team from the Nagoya University Graduate School of Medicine, Japan, discovered three gut bacteria types that may lead to predicting and treating dementia with Lewy bodies.

    Mar 23, 2023
  • Lupus Patients Can Expect At-Home Test For Kidney Inflammation

    Diagnostics World News | A smartphone-based app and test kit for lupus nephritis may start making its way to neighborhood CVS and Walgreens stores in another few years. The urine test has been shown to detect the protein ALCAM (activated leukocyte cell adhesion molecule) to distinguish lupus patients with and without the condition with 86% accuracy in multiple cohorts.

    Mar 22, 2023
  • Coronary Heart Disease Can Now Be Detected Early In The Blood

    Diagnostics World News | The worlds of genetics, epigenetics, and artificial intelligence have united to enable development of a blood test for the early detection of coronary heart disease. Newly launched in the U.S. by Cardio Diagnostics, PrecisionCHD is underpinned by the same technology as the company’s predecessor Epi+Gen CHD risk assessment test but using a different set of genetic and DNA methylation biomarkers.

    Mar 21, 2023
  • MRD in 2023: Current Capabilities, Differing Approaches, and Tests on the Horizon

    Diagnostics World News | An array of diagnostics companies have set their sights on developing minimal residual disease tests capable of detecting low levels of cancer cells remaining in the body following surgery or other types of treatment. The aim is to help measure response to therapy and identify patients at risk of relapse.

    Mar 16, 2023
  • New Telomere Measuring Method Addressing Limitations Of Current Options

    Diagnostics World News | A research collaboration led by led by Duke-NUS Medical School and National Heart Centre Singapore has set the stage for telomere measurement to one day be added to the list of clinical-grade methods for assessing biological aging. The focus is on rapid and precise measurement of individual telomeres using a technique that employs “telobaits” that latch onto the ends of telomeres in large pools of DNA fragments.

    Mar 14, 2023